A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
Abstract Background The FLAIR trial in chronic lymphocytic leukaemia has a randomised, controlled, open-label, confirmatory, platform design. FLAIR was successfully amended to include an emerging promising experimental therapy to expedite its assessment, greatly reducing the time to reach the primar...
Main Authors: | Dena R. Howard, Anna Hockaday, Julia M. Brown, Walter M. Gregory, Susan Todd, Tahla Munir, Jamie B. Oughton, Claire Dimbleby, Peter Hillmen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-020-04971-2 |
Similar Items
-
Design considerations for clinical trials in aphasia
by: Rebecca Palmer
Published: (2020-01-01) -
GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial
by: Jamie B. Oughton, et al.
Published: (2017-07-01) -
Changes to aspects of ongoing randomised controlled trials with fixed designs
by: Xanthi Coskinas, et al.
Published: (2020-06-01) -
Spotlight on landmark oncology trials: the latest evidence and novel trial designs
by: Helena Earl, et al.
Published: (2017-06-01) -
Methodology series module 4: Clinical trials
by: Maninder Singh Setia
Published: (2016-01-01)